» Articles » PMID: 22728263

The Kinetics and Reproducibility of 18F-sodium Fluoride for Oncology Using Current PET Camera Technology

Overview
Journal J Nucl Med
Specialty Nuclear Medicine
Date 2012 Jun 26
PMID 22728263
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: We evaluated the kinetics of (18)F-sodium fluoride (NaF) and reassessed the recommended dose, optimal uptake period, and reproducibility using a current-generation PET/CT scanner.

Methods: In this prospective study, 73 patients (31 patients with multiple myeloma or myeloma precursor disease and 42 with prostate cancer) were injected with a mean administered dose of 141 MBq of (18)F-NaF. Sixty patients underwent 3 sequential sessions of 3-dimensional PET/CT of the torso beginning approximately 15 min after (18)F-NaF injection, followed by whole-body 3-dimensional PET/CT at 2 h. The remaining 13 prostate cancer patients were imaged only at 2 and 3 h after injection. Twenty-one prostate cancer patients underwent repeated baseline studies (mean interval, 5.9 d) to evaluate reproducibility.

Results: The measured effective dose was 0.017 mSv/MBq, with the urinary bladder, osteogenic cells, and red marrow receiving the highest doses at 0.080, 0.077, and 0.028 mGy/MBq, respectively. Visual analysis showed that uptake in both normal and abnormal bone increased with time; however, the rate of increase decreased with time. A semiautomated workflow provided objective uptake parameters, including the mean standardized uptake value of all pixels within bone with SUVs greater than 10 and the average of the mean SUV of all malignant lesions identified by the algorithm. The values of these parameters for the images beginning at approximately 15 min and approximately 35 min were significantly different (0.3% change per minute). Differences between the later imaging time points were not significant (P < 0.01). Repeated baseline studies showed high intraclass correlations (>0.9) and relatively low critical percentage change (the value above which a change can be considered real) for these parameters. The tumor-to-normal bone ratio, based on the maximum SUV of identified malignant lesions, decreased with time; however, this difference was small, estimated at approximately 0.16%/min in the first hour.

Conclusion: (18)F-NaF PET/CT images obtained with modest radiation exposures can result in highly reproducible imaging parameters. Although the tumor-to-normal bone ratio decreases slightly with time, the high temporal dependence during uptake periods less than 30 min may limit accurate quantitation. An uptake period of 60 ± 30 min has limited temporal dependence while maintaining a high tumor-to-normal bone ratio.

Citing Articles

A systematic evaluation of five different image-derived input functions for the clinical implementation of F-NaF bone PET/CT in patients with chronic kidney disease-mineral and bone disorder.

Theil J, Vrist M, Bech J, Fynbo C Front Nucl Med. 2024; 3:1235800.

PMID: 39355022 PMC: 11440843. DOI: 10.3389/fnume.2023.1235800.


New Perspectives for Estimating Body Composition From Computed Tomography: Clothing Associated Artifacts.

Rentz L, Malone B, Vettiyil B, Sillaste E, Mizener A, Clayton S Acad Radiol. 2024; 31(6):2620-2626.

PMID: 38355363 PMC: 11214598. DOI: 10.1016/j.acra.2024.01.013.


Deep Learning-Based Detection and Classification of Bone Lesions on Staging Computed Tomography in Prostate Cancer: A Development Study.

Belue M, Harmon S, Yang D, An J, Gaur S, Law Y Acad Radiol. 2024; 31(6):2424-2433.

PMID: 38262813 PMC: 11214604. DOI: 10.1016/j.acra.2024.01.009.


Transfer Learning-Based Multi-Scale Denoising Convolutional Neural Network for Prostate Cancer Detection.

Chui K, Gupta B, Chi H, Arya V, Alhalabi W, Ruiz M Cancers (Basel). 2022; 14(15).

PMID: 35954350 PMC: 9367349. DOI: 10.3390/cancers14153687.


Whole-Body [F]-Fluoride PET SUV Imaging to Monitor Response to Dasatinib Therapy in Castration-Resistant Prostate Cancer Bone Metastases: Secondary Results from ACRIN 6687.

Muzi M, OSullivan F, Perk T, Muzi J, Mankoff D, Jeraj R Tomography. 2021; 7(2):139-153.

PMID: 33923126 PMC: 8167705. DOI: 10.3390/tomography7020013.


References
1.
Blake G, Park-Holohan S, Cook G, Fogelman I . Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonate. Semin Nucl Med. 2001; 31(1):28-49. DOI: 10.1053/snuc.2001.18742. View

2.
. Human alimentary tract model for radiological protection. ICRP Publication 100. A report of The International Commission on Radiological Protection. Ann ICRP. 2006; 36(1-2):25-327, iii. DOI: 10.1016/j.icrp.2006.03.004. View

3.
French R, McCready V . The use of 18-F for bone scanning. Br J Radiol. 1967; 40(477):655-61. DOI: 10.1259/0007-1285-40-477-655. View

4.
Grant F, Fahey F, Packard A, Davis R, Alavi A, Treves S . Skeletal PET with 18F-fluoride: applying new technology to an old tracer. J Nucl Med. 2007; 49(1):68-78. DOI: 10.2967/jnumed.106.037200. View

5.
Schirrmeister H, Guhlmann A, Kotzerke J, Santjohanser C, Kuhn T, Kreienberg R . Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography. J Clin Oncol. 1999; 17(8):2381-9. DOI: 10.1200/JCO.1999.17.8.2381. View